Drug Profile
Research programme: bone disorders therapeutics - Organon
Alternative Names: Research programme: osteoporosis therapeutics - OrganonLatest Information Update: 25 Jul 2008
Price :
$50
*
At a glance
- Originator Nonindustrial sources; Organon
- Developer Organon
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bone disorders; Osteoporosis
Most Recent Events
- 22 Mar 2004 Preclinical trials in Bone disorders in Netherlands (unspecified route)
- 22 Mar 2004 Preclinical trials in Osteoporosis in Netherlands (unspecified route)